 This study reports that mesenchymal stem cells, MSCs, can deliver sci-5-tagged antimir9 to glioblastoma multiformi, GBM, cells, which reverses the expression of the drug eflux transporter and sensitizes GBM cells to temazolamide. This article was authored by Jesse and Almonios, Sarah A. Bliss, Steven J. Greco and others.